CME Group rises as Citi upgrades to 'buy'

Derivatives exchange operator CME Group's CME.O shares rise 1% to $267 premarket

Citi upgrades CME to "buy" from "hold," citing catalysts ahead

Brokerage sees a robust capital return over the next four months as it expects CME to return proceeds from OSSTRA sale to shareholders

Adds CME's joint venture with FanDuel should help the firm expand its retail presence

6 of 18 brokerages rate the stock "buy" or higher, 9 "hold" and 3 "sell"; median PT $285 - data compiled by LSEG

As of last close, CME stock up 14% YTD